DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dyazide (Hydrochlorothiazide / Triamterene) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Dyazide (Hydrochlorothiazide / Triamterene). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (19)
     Retinal Detachment (3)Nausea (2)Dizziness (2)more >>

Cases resulting in a serious event (10)
     Retinal Detachment (3)Confusional State (1)Hyperkalaemia (1)more >>

Cases resulting in hospitalization (2)
     Confusional State (1)Hyperkalaemia (1)Mental Status Changes (1)

Cases resulting in disability (3)
     Retinal Detachment (3)

Cases resulting in other serious reactions (5)
     Nausea (1)Urinary Incontinence (1)Pancytopenia (1)more >>

Adverse event in 65 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-10-25

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea

Suspect drug(s):
Advair Diskus 100 / 50
    Indication: Asthma

Dyazide
    Dosage: 37.5mg per day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-19

Other drugs received by patient: Zyrtec; Singulair; Synthroid; Advair Diskus 100 / 50



Adverse event in 57 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-10-19

Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)

Adverse reactions / side effects: Retinal Detachment

Adverse event resulted in: disablity

Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
    Dosage: dosage form: vial.
    Start date: 2007-05-07
    End date: 2007-08-21

Ribavirin
    Dosage: 1200/1600 mg blinded therapy
    Administration route: Oral
    Start date: 2007-05-07
    End date: 2007-09-04

Lamictal
    Indication: Drug USE FOR Unknown Indication

Cymbalta
    Indication: Drug USE FOR Unknown Indication

Keppra
    Indication: Drug USE FOR Unknown Indication

Dyazide
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug



Adverse event in 57 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-10-19

Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)

Adverse reactions / side effects: Retinal Detachment

Adverse event resulted in: disablity

Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
    Dosage: dosage form: vial.
    Start date: 2007-05-07
    End date: 2007-08-21

Ribavirin
    Dosage: 1200/1600 mg blinded therapy
    Administration route: Oral
    Start date: 2007-05-07
    End date: 2007-09-04

Lamictal
    Indication: Drug USE FOR Unknown Indication

Cymbalta
    Indication: Drug USE FOR Unknown Indication

Keppra
    Indication: Drug USE FOR Unknown Indication

Dyazide
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug



Adverse event in 57 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-10-01

Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)

Adverse reactions / side effects: Retinal Detachment

Adverse event resulted in: disablity

Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
    Start date: 2007-05-07
    End date: 2007-08-21

Ribavirin
    Dosage: 1200/1600 mg blinded therapy
    Administration route: Oral
    Start date: 2007-05-07
    End date: 2007-09-04

Lamictal
    Indication: Drug USE FOR Unknown Indication

Cymbalta
    Indication: Drug USE FOR Unknown Indication

Keppra
    Indication: Drug USE FOR Unknown Indication

Dyazide
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug



Adverse event in 84 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-07-31

Patient: 84 year old female

Adverse reactions / side effects: Burning Sensation, Night Sweats, Middle Insomnia, Nausea

Suspect drug(s):
Dyazide
    Dosage: 1cap per day
    Administration route: Oral
    Start date: 2007-03-01
    End date: 2007-03-01

Furosemide
    Administration route: Oral
    Start date: 2007-01-01



Adverse event in 53 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-07-31

Patient: 53 year old female

Adverse reactions / side effects: Fall, Blister

Suspect drug(s):
Dyazide
    Administration route: Oral

Maxzide



Adverse event in 89 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-07-31

Patient: 89 year old female

Adverse reactions / side effects: Gallbladder Disorder

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in 90 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-07-31

Patient: 90 year old female

Adverse reactions / side effects: Balance Disorder, Dizziness, Constipation

Suspect drug(s):
Dyazide
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Hypertension

Paxil
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Depression

Other drugs received by patient: Lipitor; Xalatan



Adverse event in female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-31

Patient: female

Adverse reactions / side effects: Drug Ineffective

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in 68 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-07-31

Patient: 68 year old female

Adverse reactions / side effects: Muscle Spasms

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in 84 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-07-31

Patient: 84 year old female

Adverse reactions / side effects: Cystitis Noninfective

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)

Other drugs received by patient: Tenormin; Norvasc; Nexium; Aspirin; Lipitor



Adverse event in 87 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-07-31

Patient: 87 year old female

Adverse reactions / side effects: Lichen Planus

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in 69 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-06-28

Patient: 69 year old female, weighing 67.1 kg (147.7 pounds)

Adverse reactions / side effects: Oedema Peripheral, Self-Medication

Suspect drug(s):
Pamabrom 50
    Dosage: qd po
    Administration route: Oral
    Indication: Oedema
    Start date: 2007-06-23
    End date: 2007-06-26

Dyazide
    Dosage: qd po
    Administration route: Oral
    Indication: Oedema
    Start date: 2007-06-26
    End date: 2007-06-26



Adverse event in female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-06-15

Patient: female

Adverse reactions / side effects: Pancytopenia

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in 86 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a pharmacist from United States on 2007-05-29

Patient: 86 year old female

Adverse reactions / side effects: Confusional State, Mental Status Changes

Adverse event resulted in: hospitalization

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)

Other drugs received by patient: Synthroid; Boniva; Cartia XT; Lorazepam; CA; Pred



Adverse event in 87 year old female receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-04-25

Patient: 87 year old female

Adverse reactions / side effects: Nephrolithiasis, Kidney Infection

Suspect drug(s):
Daraprim
    Indication: Drug USE FOR Unknown Indication

Dyazide
    End date: 1988-01-01



Adverse event in receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a physician from United States on 2007-03-02

Patient:

Adverse reactions / side effects: Nausea, Dizziness

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)



Adverse event in male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a pharmacist from United States on 2007-01-25

Patient: male, weighing 70.3 kg (154.7 pounds)

Adverse reactions / side effects: Hyperkalaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)

Other drugs received by patient: Allopurinol Sodium; Proscar; Zetia; Norvasc; Fosinopril Sodium



Adverse event in 75 year old male receiving Dyazide (Hydrochlorothiazide / Triamterene)

Reported by a consumer/non-health professional from United States on 2007-01-17

Patient: 75 year old male

Adverse reactions / side effects: Urinary Incontinence

Suspect drug(s):
Dyazide (Hydrochlorothiazide / Triamterene)

Other drugs received by patient: Lipitor; Toprol-XL

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009